nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC10—Vincristine—muscle cancer	0.157	0.19	CbGbCtD
Sildenafil—ABCC10—Etoposide—muscle cancer	0.144	0.174	CbGbCtD
Sildenafil—ABCC10—Doxorubicin—muscle cancer	0.0984	0.119	CbGbCtD
Sildenafil—ABCC10—Methotrexate—muscle cancer	0.0953	0.115	CbGbCtD
Sildenafil—CYP1A1—Dacarbazine—muscle cancer	0.0703	0.085	CbGbCtD
Sildenafil—CYP2E1—Dacarbazine—muscle cancer	0.0543	0.0657	CbGbCtD
Sildenafil—ABCC4—Methotrexate—muscle cancer	0.0458	0.0554	CbGbCtD
Sildenafil—CYP3A7—Vincristine—muscle cancer	0.03	0.0363	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.03	0.0363	CbGbCtD
Sildenafil—CYP2E1—Etoposide—muscle cancer	0.0266	0.0321	CbGbCtD
Sildenafil—CYP3A5—Vincristine—muscle cancer	0.0225	0.0273	CbGbCtD
Sildenafil—CYP3A5—Etoposide—muscle cancer	0.0207	0.025	CbGbCtD
Sildenafil—CYP3A4—Vincristine—muscle cancer	0.00879	0.0106	CbGbCtD
Sildenafil—CYP2D6—Doxorubicin—muscle cancer	0.00864	0.0104	CbGbCtD
Sildenafil—CYP3A4—Etoposide—muscle cancer	0.00805	0.00974	CbGbCtD
Sildenafil—CYP3A4—Doxorubicin—muscle cancer	0.00549	0.00664	CbGbCtD
Sildenafil—PDE6C—head—muscle cancer	0.00294	0.104	CbGeAlD
Sildenafil—PDE6H—head—muscle cancer	0.00173	0.0613	CbGeAlD
Sildenafil—PDE6G—head—muscle cancer	0.00167	0.059	CbGeAlD
Sildenafil—PDE6G—testis—muscle cancer	0.00161	0.057	CbGeAlD
Sildenafil—PDE5A—smooth muscle tissue—muscle cancer	0.00102	0.0362	CbGeAlD
Sildenafil—PDE5A—renal system—muscle cancer	0.000985	0.0349	CbGeAlD
Sildenafil—ABCC5—cardiac atrium—muscle cancer	0.000807	0.0286	CbGeAlD
Sildenafil—PDE5A—tendon—muscle cancer	0.000769	0.0272	CbGeAlD
Sildenafil—ABCC10—renal system—muscle cancer	0.000753	0.0266	CbGeAlD
Sildenafil—ADORA2A—head—muscle cancer	0.000724	0.0256	CbGeAlD
Sildenafil—PDE5A—vagina—muscle cancer	0.000713	0.0253	CbGeAlD
Sildenafil—ABCC5—tendon—muscle cancer	0.000703	0.0249	CbGeAlD
Sildenafil—ADORA2A—testis—muscle cancer	0.000699	0.0247	CbGeAlD
Sildenafil—ABCC5—bone marrow—muscle cancer	0.000681	0.0241	CbGeAlD
Sildenafil—ABCC10—cardiac atrium—muscle cancer	0.000674	0.0239	CbGeAlD
Sildenafil—PDE5A—head—muscle cancer	0.000659	0.0233	CbGeAlD
Sildenafil—ABCC5—vagina—muscle cancer	0.000653	0.0231	CbGeAlD
Sildenafil—PDE5A—testis—muscle cancer	0.000637	0.0225	CbGeAlD
Sildenafil—ABCC4—renal system—muscle cancer	0.000624	0.0221	CbGeAlD
Sildenafil—ABCC10—tendon—muscle cancer	0.000588	0.0208	CbGeAlD
Sildenafil—ABCC5—testis—muscle cancer	0.000582	0.0206	CbGeAlD
Sildenafil—ABCC10—bone marrow—muscle cancer	0.000569	0.0201	CbGeAlD
Sildenafil—ABCC10—vagina—muscle cancer	0.000545	0.0193	CbGeAlD
Sildenafil—ABCC4—tendon—muscle cancer	0.000487	0.0173	CbGeAlD
Sildenafil—ABCC10—testis—muscle cancer	0.000487	0.0172	CbGeAlD
Sildenafil—ABCC4—bone marrow—muscle cancer	0.000472	0.0167	CbGeAlD
Sildenafil—CYP1A1—renal system—muscle cancer	0.000418	0.0148	CbGeAlD
Sildenafil—ABCC4—head—muscle cancer	0.000418	0.0148	CbGeAlD
Sildenafil—CYP3A5—renal system—muscle cancer	0.000409	0.0145	CbGeAlD
Sildenafil—ABCC4—testis—muscle cancer	0.000404	0.0143	CbGeAlD
Sildenafil—CYP2E1—renal system—muscle cancer	0.000382	0.0135	CbGeAlD
Sildenafil—CYP2C19—vagina—muscle cancer	0.000376	0.0133	CbGeAlD
Sildenafil—CYP1A1—cardiac atrium—muscle cancer	0.000375	0.0133	CbGeAlD
Sildenafil—CYP3A4—renal system—muscle cancer	0.000307	0.0109	CbGeAlD
Sildenafil—CYP1A1—vagina—muscle cancer	0.000303	0.0107	CbGeAlD
Sildenafil—CYP2D6—renal system—muscle cancer	0.000302	0.0107	CbGeAlD
Sildenafil—CYP2E1—tendon—muscle cancer	0.000298	0.0105	CbGeAlD
Sildenafil—CYP3A5—vagina—muscle cancer	0.000296	0.0105	CbGeAlD
Sildenafil—CYP1A1—head—muscle cancer	0.00028	0.00991	CbGeAlD
Sildenafil—CYP2E1—head—muscle cancer	0.000255	0.00904	CbGeAlD
Sildenafil—CYP2E1—testis—muscle cancer	0.000247	0.00873	CbGeAlD
Sildenafil—Pain in extremity—Doxorubicin—muscle cancer	0.000214	0.00148	CcSEcCtD
Sildenafil—Asthma—Methotrexate—muscle cancer	0.000214	0.00148	CcSEcCtD
Sildenafil—Chest pain—Etoposide—muscle cancer	0.000212	0.00146	CcSEcCtD
Sildenafil—Migraine—Doxorubicin—muscle cancer	0.000211	0.00146	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00021	0.00145	CcSEcCtD
Sildenafil—Discomfort—Etoposide—muscle cancer	0.000209	0.00145	CcSEcCtD
Sildenafil—Face oedema—Doxorubicin—muscle cancer	0.000207	0.00143	CcSEcCtD
Sildenafil—Hypersensitivity—Dactinomycin—muscle cancer	0.000207	0.00143	CcSEcCtD
Sildenafil—Gastrointestinal pain—Vincristine—muscle cancer	0.000205	0.00142	CcSEcCtD
Sildenafil—Cardiac arrest—Doxorubicin—muscle cancer	0.000204	0.00141	CcSEcCtD
Sildenafil—CYP2D6—head—muscle cancer	0.000202	0.00716	CbGeAlD
Sildenafil—Infection—Etoposide—muscle cancer	0.000202	0.00139	CcSEcCtD
Sildenafil—Ataxia—Doxorubicin—muscle cancer	0.000202	0.00139	CcSEcCtD
Sildenafil—Asthenia—Dactinomycin—muscle cancer	0.000201	0.00139	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000199	0.00137	CcSEcCtD
Sildenafil—Tachycardia—Etoposide—muscle cancer	0.000198	0.00137	CcSEcCtD
Sildenafil—Abdominal pain—Vincristine—muscle cancer	0.000198	0.00137	CcSEcCtD
Sildenafil—Body temperature increased—Vincristine—muscle cancer	0.000198	0.00137	CcSEcCtD
Sildenafil—Liver function test abnormal—Doxorubicin—muscle cancer	0.000198	0.00137	CcSEcCtD
Sildenafil—Skin disorder—Etoposide—muscle cancer	0.000197	0.00136	CcSEcCtD
Sildenafil—Erectile dysfunction—Methotrexate—muscle cancer	0.000197	0.00136	CcSEcCtD
Sildenafil—Hyperhidrosis—Etoposide—muscle cancer	0.000196	0.00136	CcSEcCtD
Sildenafil—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000196	0.00135	CcSEcCtD
Sildenafil—Abdominal pain upper—Doxorubicin—muscle cancer	0.000196	0.00135	CcSEcCtD
Sildenafil—CYP2D6—testis—muscle cancer	0.000195	0.00691	CbGeAlD
Sildenafil—Photosensitivity reaction—Methotrexate—muscle cancer	0.000195	0.00135	CcSEcCtD
Sildenafil—Hypokalaemia—Doxorubicin—muscle cancer	0.000195	0.00135	CcSEcCtD
Sildenafil—Breast disorder—Doxorubicin—muscle cancer	0.000194	0.00134	CcSEcCtD
Sildenafil—Anorexia—Etoposide—muscle cancer	0.000194	0.00134	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000193	0.00133	CcSEcCtD
Sildenafil—Diarrhoea—Dactinomycin—muscle cancer	0.000192	0.00133	CcSEcCtD
Sildenafil—Pneumonia—Methotrexate—muscle cancer	0.000192	0.00133	CcSEcCtD
Sildenafil—Nasopharyngitis—Doxorubicin—muscle cancer	0.000192	0.00132	CcSEcCtD
Sildenafil—Infestation NOS—Methotrexate—muscle cancer	0.000191	0.00132	CcSEcCtD
Sildenafil—Infestation—Methotrexate—muscle cancer	0.000191	0.00132	CcSEcCtD
Sildenafil—Depression—Methotrexate—muscle cancer	0.00019	0.00131	CcSEcCtD
Sildenafil—Hypotension—Etoposide—muscle cancer	0.00019	0.00131	CcSEcCtD
Sildenafil—Gastritis—Doxorubicin—muscle cancer	0.00019	0.00131	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000189	0.00131	CcSEcCtD
Sildenafil—Muscular weakness—Doxorubicin—muscle cancer	0.000189	0.00131	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000189	0.00131	CcSEcCtD
Sildenafil—Renal failure—Methotrexate—muscle cancer	0.000188	0.0013	CcSEcCtD
Sildenafil—Abdominal distension—Doxorubicin—muscle cancer	0.000186	0.00129	CcSEcCtD
Sildenafil—Stomatitis—Methotrexate—muscle cancer	0.000186	0.00128	CcSEcCtD
Sildenafil—Conjunctivitis—Methotrexate—muscle cancer	0.000185	0.00128	CcSEcCtD
Sildenafil—Asthma—Doxorubicin—muscle cancer	0.000185	0.00128	CcSEcCtD
Sildenafil—Influenza—Doxorubicin—muscle cancer	0.000185	0.00128	CcSEcCtD
Sildenafil—Dysphagia—Doxorubicin—muscle cancer	0.000185	0.00128	CcSEcCtD
Sildenafil—Hypersensitivity—Vincristine—muscle cancer	0.000185	0.00128	CcSEcCtD
Sildenafil—Sweating—Methotrexate—muscle cancer	0.000183	0.00126	CcSEcCtD
Sildenafil—Paraesthesia—Etoposide—muscle cancer	0.000182	0.00126	CcSEcCtD
Sildenafil—Haematuria—Methotrexate—muscle cancer	0.000182	0.00126	CcSEcCtD
Sildenafil—Dyspnoea—Etoposide—muscle cancer	0.000181	0.00125	CcSEcCtD
Sildenafil—Somnolence—Etoposide—muscle cancer	0.000181	0.00125	CcSEcCtD
Sildenafil—Angina pectoris—Doxorubicin—muscle cancer	0.00018	0.00125	CcSEcCtD
Sildenafil—Epistaxis—Methotrexate—muscle cancer	0.00018	0.00124	CcSEcCtD
Sildenafil—Asthenia—Vincristine—muscle cancer	0.00018	0.00124	CcSEcCtD
Sildenafil—Vomiting—Dactinomycin—muscle cancer	0.000178	0.00123	CcSEcCtD
Sildenafil—Bronchitis—Doxorubicin—muscle cancer	0.000178	0.00123	CcSEcCtD
Sildenafil—Rash—Dactinomycin—muscle cancer	0.000177	0.00122	CcSEcCtD
Sildenafil—Decreased appetite—Etoposide—muscle cancer	0.000177	0.00122	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Etoposide—muscle cancer	0.000175	0.00121	CcSEcCtD
Sildenafil—Fatigue—Etoposide—muscle cancer	0.000175	0.00121	CcSEcCtD
Sildenafil—Pain—Etoposide—muscle cancer	0.000174	0.0012	CcSEcCtD
Sildenafil—Constipation—Etoposide—muscle cancer	0.000174	0.0012	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000172	0.00119	CcSEcCtD
Sildenafil—Haemoglobin—Methotrexate—muscle cancer	0.000172	0.00119	CcSEcCtD
Sildenafil—Diarrhoea—Vincristine—muscle cancer	0.000172	0.00118	CcSEcCtD
Sildenafil—Haemorrhage—Methotrexate—muscle cancer	0.000171	0.00118	CcSEcCtD
Sildenafil—Pollakiuria—Doxorubicin—muscle cancer	0.000171	0.00118	CcSEcCtD
Sildenafil—Pharyngitis—Methotrexate—muscle cancer	0.00017	0.00117	CcSEcCtD
Sildenafil—Urinary tract disorder—Methotrexate—muscle cancer	0.000169	0.00117	CcSEcCtD
Sildenafil—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000169	0.00117	CcSEcCtD
Sildenafil—Weight increased—Doxorubicin—muscle cancer	0.000169	0.00116	CcSEcCtD
Sildenafil—Urethral disorder—Methotrexate—muscle cancer	0.000168	0.00116	CcSEcCtD
Sildenafil—Feeling abnormal—Etoposide—muscle cancer	0.000167	0.00116	CcSEcCtD
Sildenafil—Hyperglycaemia—Doxorubicin—muscle cancer	0.000167	0.00115	CcSEcCtD
Sildenafil—Nausea—Dactinomycin—muscle cancer	0.000167	0.00115	CcSEcCtD
Sildenafil—Pneumonia—Doxorubicin—muscle cancer	0.000166	0.00115	CcSEcCtD
Sildenafil—Gastrointestinal pain—Etoposide—muscle cancer	0.000166	0.00115	CcSEcCtD
Sildenafil—Dizziness—Vincristine—muscle cancer	0.000166	0.00115	CcSEcCtD
Sildenafil—Infestation NOS—Doxorubicin—muscle cancer	0.000165	0.00114	CcSEcCtD
Sildenafil—Infestation—Doxorubicin—muscle cancer	0.000165	0.00114	CcSEcCtD
Sildenafil—Visual impairment—Methotrexate—muscle cancer	0.000165	0.00114	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000164	0.00113	CcSEcCtD
Sildenafil—Renal failure—Doxorubicin—muscle cancer	0.000162	0.00112	CcSEcCtD
Sildenafil—Erythema multiforme—Methotrexate—muscle cancer	0.000162	0.00112	CcSEcCtD
Sildenafil—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000162	0.00112	CcSEcCtD
Sildenafil—Urticaria—Etoposide—muscle cancer	0.000161	0.00111	CcSEcCtD
Sildenafil—Stomatitis—Doxorubicin—muscle cancer	0.000161	0.00111	CcSEcCtD
Sildenafil—Abdominal pain—Etoposide—muscle cancer	0.000161	0.00111	CcSEcCtD
Sildenafil—Body temperature increased—Etoposide—muscle cancer	0.000161	0.00111	CcSEcCtD
Sildenafil—Urinary tract infection—Doxorubicin—muscle cancer	0.000161	0.00111	CcSEcCtD
Sildenafil—Conjunctivitis—Doxorubicin—muscle cancer	0.000161	0.00111	CcSEcCtD
Sildenafil—Eye disorder—Methotrexate—muscle cancer	0.00016	0.00111	CcSEcCtD
Sildenafil—Tinnitus—Methotrexate—muscle cancer	0.00016	0.0011	CcSEcCtD
Sildenafil—Vomiting—Vincristine—muscle cancer	0.000159	0.0011	CcSEcCtD
Sildenafil—Cardiac disorder—Methotrexate—muscle cancer	0.000159	0.0011	CcSEcCtD
Sildenafil—Sweating—Doxorubicin—muscle cancer	0.000158	0.00109	CcSEcCtD
Sildenafil—Rash—Vincristine—muscle cancer	0.000158	0.00109	CcSEcCtD
Sildenafil—Dermatitis—Vincristine—muscle cancer	0.000158	0.00109	CcSEcCtD
Sildenafil—Haematuria—Doxorubicin—muscle cancer	0.000157	0.00109	CcSEcCtD
Sildenafil—Headache—Vincristine—muscle cancer	0.000157	0.00108	CcSEcCtD
Sildenafil—Epistaxis—Doxorubicin—muscle cancer	0.000156	0.00108	CcSEcCtD
Sildenafil—Angiopathy—Methotrexate—muscle cancer	0.000155	0.00107	CcSEcCtD
Sildenafil—Sinusitis—Doxorubicin—muscle cancer	0.000155	0.00107	CcSEcCtD
Sildenafil—Immune system disorder—Methotrexate—muscle cancer	0.000155	0.00107	CcSEcCtD
Sildenafil—Mediastinal disorder—Methotrexate—muscle cancer	0.000154	0.00107	CcSEcCtD
Sildenafil—Chills—Methotrexate—muscle cancer	0.000154	0.00106	CcSEcCtD
Sildenafil—Alopecia—Methotrexate—muscle cancer	0.000151	0.00105	CcSEcCtD
Sildenafil—Mental disorder—Methotrexate—muscle cancer	0.00015	0.00104	CcSEcCtD
Sildenafil—Hypersensitivity—Etoposide—muscle cancer	0.00015	0.00103	CcSEcCtD
Sildenafil—Malnutrition—Methotrexate—muscle cancer	0.000149	0.00103	CcSEcCtD
Sildenafil—Erythema—Methotrexate—muscle cancer	0.000149	0.00103	CcSEcCtD
Sildenafil—Haemoglobin—Doxorubicin—muscle cancer	0.000149	0.00103	CcSEcCtD
Sildenafil—Nausea—Vincristine—muscle cancer	0.000149	0.00103	CcSEcCtD
Sildenafil—Rhinitis—Doxorubicin—muscle cancer	0.000149	0.00103	CcSEcCtD
Sildenafil—Haemorrhage—Doxorubicin—muscle cancer	0.000148	0.00102	CcSEcCtD
Sildenafil—Hypoaesthesia—Doxorubicin—muscle cancer	0.000148	0.00102	CcSEcCtD
Sildenafil—Pharyngitis—Doxorubicin—muscle cancer	0.000147	0.00102	CcSEcCtD
Sildenafil—Urinary tract disorder—Doxorubicin—muscle cancer	0.000146	0.00101	CcSEcCtD
Sildenafil—Oedema peripheral—Doxorubicin—muscle cancer	0.000146	0.00101	CcSEcCtD
Sildenafil—Asthenia—Etoposide—muscle cancer	0.000146	0.00101	CcSEcCtD
Sildenafil—Connective tissue disorder—Doxorubicin—muscle cancer	0.000146	0.00101	CcSEcCtD
Sildenafil—Urethral disorder—Doxorubicin—muscle cancer	0.000145	0.001	CcSEcCtD
Sildenafil—Back pain—Methotrexate—muscle cancer	0.000144	0.000996	CcSEcCtD
Sildenafil—Pruritus—Etoposide—muscle cancer	0.000144	0.000993	CcSEcCtD
Sildenafil—Visual impairment—Doxorubicin—muscle cancer	0.000143	0.000987	CcSEcCtD
Sildenafil—Vision blurred—Methotrexate—muscle cancer	0.00014	0.00097	CcSEcCtD
Sildenafil—Erythema multiforme—Doxorubicin—muscle cancer	0.00014	0.000968	CcSEcCtD
Sildenafil—Diarrhoea—Etoposide—muscle cancer	0.000139	0.00096	CcSEcCtD
Sildenafil—Eye disorder—Doxorubicin—muscle cancer	0.000139	0.000957	CcSEcCtD
Sildenafil—Ill-defined disorder—Methotrexate—muscle cancer	0.000138	0.000955	CcSEcCtD
Sildenafil—Tinnitus—Doxorubicin—muscle cancer	0.000138	0.000955	CcSEcCtD
Sildenafil—Anaemia—Methotrexate—muscle cancer	0.000138	0.000952	CcSEcCtD
Sildenafil—Flushing—Doxorubicin—muscle cancer	0.000138	0.000951	CcSEcCtD
Sildenafil—Cardiac disorder—Doxorubicin—muscle cancer	0.000138	0.000951	CcSEcCtD
Sildenafil—Angiopathy—Doxorubicin—muscle cancer	0.000135	0.000929	CcSEcCtD
Sildenafil—Malaise—Methotrexate—muscle cancer	0.000134	0.000929	CcSEcCtD
Sildenafil—Dizziness—Etoposide—muscle cancer	0.000134	0.000928	CcSEcCtD
Sildenafil—Immune system disorder—Doxorubicin—muscle cancer	0.000134	0.000925	CcSEcCtD
Sildenafil—Vertigo—Methotrexate—muscle cancer	0.000134	0.000925	CcSEcCtD
Sildenafil—Mediastinal disorder—Doxorubicin—muscle cancer	0.000134	0.000923	CcSEcCtD
Sildenafil—Leukopenia—Methotrexate—muscle cancer	0.000133	0.000922	CcSEcCtD
Sildenafil—Chills—Doxorubicin—muscle cancer	0.000133	0.000919	CcSEcCtD
Sildenafil—Arrhythmia—Doxorubicin—muscle cancer	0.000132	0.000915	CcSEcCtD
Sildenafil—Alopecia—Doxorubicin—muscle cancer	0.000131	0.000905	CcSEcCtD
Sildenafil—Cough—Methotrexate—muscle cancer	0.00013	0.000899	CcSEcCtD
Sildenafil—Mental disorder—Doxorubicin—muscle cancer	0.00013	0.000897	CcSEcCtD
Sildenafil—Convulsion—Methotrexate—muscle cancer	0.000129	0.000892	CcSEcCtD
Sildenafil—Vomiting—Etoposide—muscle cancer	0.000129	0.000892	CcSEcCtD
Sildenafil—Erythema—Doxorubicin—muscle cancer	0.000129	0.000892	CcSEcCtD
Sildenafil—Malnutrition—Doxorubicin—muscle cancer	0.000129	0.000892	CcSEcCtD
Sildenafil—Rash—Etoposide—muscle cancer	0.000128	0.000885	CcSEcCtD
Sildenafil—Dermatitis—Etoposide—muscle cancer	0.000128	0.000884	CcSEcCtD
Sildenafil—Headache—Etoposide—muscle cancer	0.000127	0.000879	CcSEcCtD
Sildenafil—Flatulence—Doxorubicin—muscle cancer	0.000127	0.000879	CcSEcCtD
Sildenafil—Arthralgia—Methotrexate—muscle cancer	0.000127	0.000877	CcSEcCtD
Sildenafil—Chest pain—Methotrexate—muscle cancer	0.000127	0.000877	CcSEcCtD
Sildenafil—Myalgia—Methotrexate—muscle cancer	0.000127	0.000877	CcSEcCtD
Sildenafil—Tension—Doxorubicin—muscle cancer	0.000127	0.000875	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000126	0.000871	CcSEcCtD
Sildenafil—Discomfort—Methotrexate—muscle cancer	0.000125	0.000866	CcSEcCtD
Sildenafil—Nervousness—Doxorubicin—muscle cancer	0.000125	0.000866	CcSEcCtD
Sildenafil—Back pain—Doxorubicin—muscle cancer	0.000125	0.000862	CcSEcCtD
Sildenafil—Vision blurred—Doxorubicin—muscle cancer	0.000122	0.00084	CcSEcCtD
Sildenafil—Infection—Methotrexate—muscle cancer	0.000121	0.000835	CcSEcCtD
Sildenafil—Nausea—Etoposide—muscle cancer	0.000121	0.000833	CcSEcCtD
Sildenafil—Ill-defined disorder—Doxorubicin—muscle cancer	0.00012	0.000827	CcSEcCtD
Sildenafil—Nervous system disorder—Methotrexate—muscle cancer	0.000119	0.000824	CcSEcCtD
Sildenafil—Anaemia—Doxorubicin—muscle cancer	0.000119	0.000824	CcSEcCtD
Sildenafil—Agitation—Doxorubicin—muscle cancer	0.000119	0.000819	CcSEcCtD
Sildenafil—Skin disorder—Methotrexate—muscle cancer	0.000118	0.000816	CcSEcCtD
Sildenafil—Hyperhidrosis—Methotrexate—muscle cancer	0.000118	0.000812	CcSEcCtD
Sildenafil—Malaise—Doxorubicin—muscle cancer	0.000116	0.000804	CcSEcCtD
Sildenafil—Vertigo—Doxorubicin—muscle cancer	0.000116	0.000801	CcSEcCtD
Sildenafil—Anorexia—Methotrexate—muscle cancer	0.000116	0.000801	CcSEcCtD
Sildenafil—Syncope—Doxorubicin—muscle cancer	0.000116	0.0008	CcSEcCtD
Sildenafil—Leukopenia—Doxorubicin—muscle cancer	0.000116	0.000798	CcSEcCtD
Sildenafil—Palpitations—Doxorubicin—muscle cancer	0.000114	0.000788	CcSEcCtD
Sildenafil—Hypotension—Methotrexate—muscle cancer	0.000114	0.000785	CcSEcCtD
Sildenafil—Loss of consciousness—Doxorubicin—muscle cancer	0.000113	0.000784	CcSEcCtD
Sildenafil—Cough—Doxorubicin—muscle cancer	0.000113	0.000778	CcSEcCtD
Sildenafil—Convulsion—Doxorubicin—muscle cancer	0.000112	0.000773	CcSEcCtD
Sildenafil—Hypertension—Doxorubicin—muscle cancer	0.000111	0.00077	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000111	0.000766	CcSEcCtD
Sildenafil—Insomnia—Methotrexate—muscle cancer	0.00011	0.00076	CcSEcCtD
Sildenafil—Arthralgia—Doxorubicin—muscle cancer	0.00011	0.000759	CcSEcCtD
Sildenafil—Myalgia—Doxorubicin—muscle cancer	0.00011	0.000759	CcSEcCtD
Sildenafil—Chest pain—Doxorubicin—muscle cancer	0.00011	0.000759	CcSEcCtD
Sildenafil—Anxiety—Doxorubicin—muscle cancer	0.00011	0.000756	CcSEcCtD
Sildenafil—Paraesthesia—Methotrexate—muscle cancer	0.000109	0.000755	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000109	0.000754	CcSEcCtD
Sildenafil—Discomfort—Doxorubicin—muscle cancer	0.000109	0.00075	CcSEcCtD
Sildenafil—Dyspnoea—Methotrexate—muscle cancer	0.000108	0.000749	CcSEcCtD
Sildenafil—Somnolence—Methotrexate—muscle cancer	0.000108	0.000747	CcSEcCtD
Sildenafil—Dry mouth—Doxorubicin—muscle cancer	0.000107	0.000742	CcSEcCtD
Sildenafil—Dyspepsia—Methotrexate—muscle cancer	0.000107	0.00074	CcSEcCtD
Sildenafil—Decreased appetite—Methotrexate—muscle cancer	0.000106	0.000731	CcSEcCtD
Sildenafil—Oedema—Doxorubicin—muscle cancer	0.000105	0.000728	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000105	0.000726	CcSEcCtD
Sildenafil—Fatigue—Methotrexate—muscle cancer	0.000105	0.000725	CcSEcCtD
Sildenafil—Infection—Doxorubicin—muscle cancer	0.000105	0.000723	CcSEcCtD
Sildenafil—Pain—Methotrexate—muscle cancer	0.000104	0.000719	CcSEcCtD
Sildenafil—Shock—Doxorubicin—muscle cancer	0.000104	0.000716	CcSEcCtD
Sildenafil—Nervous system disorder—Doxorubicin—muscle cancer	0.000103	0.000714	CcSEcCtD
Sildenafil—Tachycardia—Doxorubicin—muscle cancer	0.000103	0.00071	CcSEcCtD
Sildenafil—Skin disorder—Doxorubicin—muscle cancer	0.000102	0.000707	CcSEcCtD
Sildenafil—Hyperhidrosis—Doxorubicin—muscle cancer	0.000102	0.000703	CcSEcCtD
Sildenafil—Anorexia—Doxorubicin—muscle cancer	0.0001	0.000694	CcSEcCtD
Sildenafil—Feeling abnormal—Methotrexate—muscle cancer	0.0001	0.000693	CcSEcCtD
Sildenafil—Gastrointestinal pain—Methotrexate—muscle cancer	9.95e-05	0.000687	CcSEcCtD
Sildenafil—Hypotension—Doxorubicin—muscle cancer	9.84e-05	0.00068	CcSEcCtD
Sildenafil—Urticaria—Methotrexate—muscle cancer	9.67e-05	0.000668	CcSEcCtD
Sildenafil—Body temperature increased—Methotrexate—muscle cancer	9.62e-05	0.000664	CcSEcCtD
Sildenafil—Abdominal pain—Methotrexate—muscle cancer	9.62e-05	0.000664	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Doxorubicin—muscle cancer	9.6e-05	0.000663	CcSEcCtD
Sildenafil—Insomnia—Doxorubicin—muscle cancer	9.53e-05	0.000658	CcSEcCtD
Sildenafil—Paraesthesia—Doxorubicin—muscle cancer	9.46e-05	0.000653	CcSEcCtD
Sildenafil—Dyspnoea—Doxorubicin—muscle cancer	9.39e-05	0.000649	CcSEcCtD
Sildenafil—Somnolence—Doxorubicin—muscle cancer	9.37e-05	0.000647	CcSEcCtD
Sildenafil—Dyspepsia—Doxorubicin—muscle cancer	9.27e-05	0.000641	CcSEcCtD
Sildenafil—Decreased appetite—Doxorubicin—muscle cancer	9.16e-05	0.000633	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Doxorubicin—muscle cancer	9.1e-05	0.000628	CcSEcCtD
Sildenafil—Fatigue—Doxorubicin—muscle cancer	9.08e-05	0.000627	CcSEcCtD
Sildenafil—Constipation—Doxorubicin—muscle cancer	9.01e-05	0.000622	CcSEcCtD
Sildenafil—Pain—Doxorubicin—muscle cancer	9.01e-05	0.000622	CcSEcCtD
Sildenafil—Hypersensitivity—Methotrexate—muscle cancer	8.96e-05	0.000619	CcSEcCtD
Sildenafil—Asthenia—Methotrexate—muscle cancer	8.73e-05	0.000603	CcSEcCtD
Sildenafil—Feeling abnormal—Doxorubicin—muscle cancer	8.68e-05	0.0006	CcSEcCtD
Sildenafil—Gastrointestinal pain—Doxorubicin—muscle cancer	8.61e-05	0.000595	CcSEcCtD
Sildenafil—Pruritus—Methotrexate—muscle cancer	8.61e-05	0.000595	CcSEcCtD
Sildenafil—Urticaria—Doxorubicin—muscle cancer	8.37e-05	0.000578	CcSEcCtD
Sildenafil—Body temperature increased—Doxorubicin—muscle cancer	8.33e-05	0.000575	CcSEcCtD
Sildenafil—Abdominal pain—Doxorubicin—muscle cancer	8.33e-05	0.000575	CcSEcCtD
Sildenafil—Diarrhoea—Methotrexate—muscle cancer	8.32e-05	0.000575	CcSEcCtD
Sildenafil—Dizziness—Methotrexate—muscle cancer	8.05e-05	0.000556	CcSEcCtD
Sildenafil—Hypersensitivity—Doxorubicin—muscle cancer	7.76e-05	0.000536	CcSEcCtD
Sildenafil—Vomiting—Methotrexate—muscle cancer	7.74e-05	0.000534	CcSEcCtD
Sildenafil—Rash—Methotrexate—muscle cancer	7.67e-05	0.00053	CcSEcCtD
Sildenafil—Dermatitis—Methotrexate—muscle cancer	7.66e-05	0.000529	CcSEcCtD
Sildenafil—Headache—Methotrexate—muscle cancer	7.62e-05	0.000526	CcSEcCtD
Sildenafil—Asthenia—Doxorubicin—muscle cancer	7.56e-05	0.000522	CcSEcCtD
Sildenafil—Pruritus—Doxorubicin—muscle cancer	7.45e-05	0.000515	CcSEcCtD
Sildenafil—Nausea—Methotrexate—muscle cancer	7.23e-05	0.000499	CcSEcCtD
Sildenafil—Diarrhoea—Doxorubicin—muscle cancer	7.21e-05	0.000498	CcSEcCtD
Sildenafil—Dizziness—Doxorubicin—muscle cancer	6.97e-05	0.000481	CcSEcCtD
Sildenafil—Vomiting—Doxorubicin—muscle cancer	6.7e-05	0.000463	CcSEcCtD
Sildenafil—Rash—Doxorubicin—muscle cancer	6.64e-05	0.000459	CcSEcCtD
Sildenafil—Dermatitis—Doxorubicin—muscle cancer	6.64e-05	0.000458	CcSEcCtD
Sildenafil—Headache—Doxorubicin—muscle cancer	6.6e-05	0.000456	CcSEcCtD
Sildenafil—Nausea—Doxorubicin—muscle cancer	6.26e-05	0.000432	CcSEcCtD
